<DOC>
	<DOCNO>NCT02637128</DOCNO>
	<brief_summary>This study design determine efficacy artemether-lumefantrine artesunate-amodiaquine ( compare efficacy two drug ) treatment uncomplicated Plasmodium falciparum malaria Machinga , Nkhotakota , Karonga District Hospitals- Malawi .</brief_summary>
	<brief_title>In Vivo Efficacy Artemether-Lumefantrine Artesunate-Amodiaquine Uncomplicated P. Falciparum Malaria</brief_title>
	<detailed_description>Background : Malaria cause substantial morbidity mortality Malawi . Prompt effective treatment uncomplicated malaria remain key strategy reduce public health burden malaria . Due rise resistance decline efficacy sulfadoxine-pyrimethamine , first-line treatment uncomplicated malaria 1993 2007 , National Malaria Control Program ( NMCP ) revise national treatment guideline 2007 2013 . The revised treatment guideline recommend artemether-lumefantrine first-line treatment uncomplicated malaria artesunate-amodiaquine second-line treatment uncomplicated malaria . Data Malawi suggest drug remain efficacious . In study conduct 2004-2006 Blantyre , artemether-lumefantrine find efficacious . A recent assessment artemether-lumefantrine vivo efficacy conduct six site Malawi 2009 also suggest standard formulation artemether-lumefantrine remain highly efficacious . In addition , dispersible formulation artemether-lumefantrine ( Coartem-D™ ) artesunate-amodiaquine extremely well tolerate safe study conduct Malawi well Sub-Saharan African country . Given potential development parasite resistance , imperative continue monitor efficacy drug long remain recommended treatment regimen . Objective : Determine efficacy artemether-lumefantrine co-formulated artesunate-amodiaquine treatment uncomplicated Plasmodium falciparum malaria Machinga , Nkhotakota , Karonga District Hospitals- Malawi Methods : A randomized drug efficacy trial conduct Malawi . The trial include 453 febrile child 6-59 month old confirm uncomplicated P. falciparum infection , seek care Machinga , Nkhotakota , Karonga District Hospitals ; 151 patient enrol site ( 113 artemether-lumefantrine 38 co-formulated artesunate-amodiaquine ) . Patients randomize receive treatment either dispersible formulation artemether-lumefantrine dose 2/12 mg/kg body weight artemether lumefantrine , respectively , per dose , give twice day 3 day ; co-formulated artesunate-amodiaquine dose 4 mg/kg/day artesunate 10 mg/kg/day amodiaquine day 3 day . Clinical parasitological parameter monitor 28-day follow-up period evaluate drug efficacy .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<criteria>age 6 59 month monoinfection P. falciparum detect microscopy parasitaemia 1,000200,000/µl asexual form presence axillary temperature ≥ 37.5 °C history fever past 24 h ability swallow oral medication ability willingness comply study protocol duration study comply study visit schedule inform consent parent guardian child presence general danger sign child age 659 month sign severe falciparum malaria accord definition World Health Organization mixed monoinfection another Plasmodium specie detect microscopy presence severe malnutrition ( defined child whose growth standard 3 zscore ) presence febrile condition due disease malaria ( e.g . measles , acute low respiratory tract infection , severe diarrhoea dehydration ) know underlie chronic severe disease ( e.g . cardiac , renal hepatic disease , HIV/AIDS ) regular medication may interfere antimalarial pharmacokinetics history hypersensitivity reaction contraindication medicine test used alternative treatment</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>MALARIA , FALCIPARUM</keyword>
	<keyword>MALAWI</keyword>
	<keyword>ARTEMETHER-LUMEFANTRINE</keyword>
	<keyword>ARTESUNATE-AMODIAQUINE</keyword>
</DOC>